Marcos Daccarett, MD
Clinical Cardiac Electrophysiology · Boise, IDNPI 1023144300
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $113,063 of the $154,066 with a category attached, or 73.4%. Boston Scientific accounts for 96.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $64,174, 7.2 times the $8,852 reported in 2019.
Across 697 payments — averaging $221.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$149K
- Abbott$2K
- Biosense Webster, Inc.$1K
- ZOLL Respicardia, Inc.$1K
- Medtronic$135
- Johnson & Johnson$130
- plus $304 from 5 others
Across 132 payments — averaging $2800.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$370K
What the payments were for
- Consulting fees$13,3139%
- Speaking & faculty fees$113,06373%
- Travel & lodging$11,2717%
- Food & beverage$16,42011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 657 | $149,151 |
| Abbott | 12 | $2,283 |
| Biosense Webster, Inc. | 10 | $1,043 |
| ZOLL Respicardia, Inc. | 3 | $1,020 |
| Medtronic(2 entities) | 7 | $135 |
| Johnson & Johnson | 1 | $130 |
| Impulse Dynamics (USA) Inc. | 1 | $121 |
| Itamar Medical Inc | 1 | $97 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Irhythm Technologies, Inc. | 1 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL EP$46,665
- Rhythmia Mapping System$32,000
- RHYTHMIA$11,456
- Farapulse$10,931
- WATCHMAN Access System$2,724
- GENERAL - THERAPIES$2,564
- AMPLATZER AMULET$1,239
- Watchman$1,228
- remede System$1,020
- Accent Pacemaker$900
- EMBLEM$750
- Carto 3$564
- ACCOLADE SR$504
- LUX-Dx Insertable Cardiac Monitor$385
- WATCHMAN FLX$344
- EMBLEM MRI S-ICD$250
- OPTIMIZER$242
- NUVISION ICE CATHETER$238
- GENERAL TACHY$222
- QDOT MICRO Catheter$145
How this compares
Too few clinical cardiac electrophysiology providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 437 | $467,351 |
| XareltoRivaroxaban | 36 | $33,476 |
| MultaqDronedarone Hcl | 11 | $14,305 |
| Flecainide Acetate | 124 | $5,977 |
| Dofetilide | 24 | $3,680 |
| Mexiletine Hcl | 16 | $2,916 |
| Amiodarone Hcl | 95 | $2,017 |
| Metoprolol Succinate | 127 | $1,742 |
| SotalolSotalol Hcl | 64 | $1,657 |
| Digoxin | 81 | $1,509 |
| ClopidogrelClopidogrel Bisulfate | 149 | $1,501 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 60 | $1,473 |
| Warfarin Sodium | 78 | $1,187 |
| Diltiazem 24hr ErDiltiazem Hcl | 16 | $711 |
| Metoprolol Tartrate | 61 | $558 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $130 | $33,47636 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical cardiac electrophysiology providers in Idahoon file to place this against a meaningful peer group, so we don't.
Other clinical cardiac electrophysiology in Boise
- Daniel NoonanBoise$95K
- Luciano AmadoBoise$77K
- Justice OranefoBoise$30K
- Joshua MozesBoise$26K
- Adam GrimaldiBoise$25K
- Melinda MarksBoise$9K
- Petar IgicBoise$3K
- Mark RichardsPocatello$198K
- Janet OttoIdaho Falls$21K
- Michele Murphy CookCoeur D Alene$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.